Provexis plc (PXS)
LSE
Closed
Aug 25, 2026
Day's Range
1.0052 wk Range
0.00618Overview - PXS - Provexis plc
Key Statistics
Valuation
Enterprise Value
25.33M
P/E (Trailing)
‪-5,625.00‬
Price / Sales (TTM)
‪27.59‬
EV / EBITDA
‪-56.05‬
Profitability
Profit Margin
‪-69.30%‬
Operating Margin
‪-85.00%‬
Return on Assets
‪-46.13%‬
Return on Equity
‪-125.49%‬
Ownership
Shares Outstanding
2.34B
Float
1.80B
Held by Insiders
‪20.84%‬
Held by Institutions
‪9.86%‬
Price stats
Beta
‪0.66‬
50-Day Avg
‪1.17‬
200-Day Avg
‪1.04‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Peers - PXS - Provexis plc
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
Profile Summary - PXS - Provexis plc
About
Provexis plc is a public limited company specializing in the development, licensing, and commercialization of innovative functional food ingredients, particularly its proprietary Fruitflow technology. Fruitflow, a natural tomato extract available in syrup and powder forms, helps maintain normal platelet aggregation to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
